Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01EG L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG01 L01EG01 Temsirolimus
L01EG02 L01EG02 Everolimus
L01EH L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EH01 L01EH01 Lapatinib
L01EH02 L01EH02 Neratinib
L01EJ02 L01EJ02 Fedratinib
L01EL L01EL Bruton's tyrosine kinase (BTK) inhibitors
L01EL01 L01EL01 Ibrutinib
L01EL02 L01EL02 Acalabrutinib
L01EX L01EX Other protein kinase inhibitors
L01EX01 L01EX01 Imatinib
L01EX02 L01EX02 Gefitinib
L01EX03 L01EX03 Erlotinib
L01EX04 L01EX04 Sunitinib
L01EX05 L01EX05 Sorafenib
L01EX06 L01EX06 Dasatinib
L01EX07 L01EX07 Lapatinib
L01EX08 L01EX08 Nilotinib
L01EX09 L01EX09 Temsirolimus
L01EX10 L01EX10 Everolimus
L01EX11 L01EX11 Pazopanib
L01EX12 L01EX12 Vandetanib
L01EX13 L01EX13 Afatinib
L01EX13 L01EX13 Gilteritinib
L01EX14 L01EX14 Bosutinib
L01EX15 L01EX15 Vemurafenib
L01EX16 L01EX16 Crizotinib
L01EX17 L01EX17 Axitinib
L01EX18 L01EX18 Avapritinib
Showing 30 of 6884 Records